Original Research
Accepted on 04 Oct 2024
A novel chimeric endolysin Cly2v shows potential in treating streptococci-induced bovine mastitis and systemic infections
in Antimicrobials, Resistance and Chemotherapy
- 818 views
Original Research
Accepted on 04 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 03 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Review
Published on 03 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 03 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 02 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 02 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 02 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 01 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 01 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 01 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 01 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Editorial
Published on 01 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 01 Oct 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 30 Sep 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 30 Sep 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 30 Sep 2024
in Antimicrobials, Resistance and Chemotherapy